Form 4: Sabra Health Care REIT Director, Clifton J. Porter II, Reports Stock Grant and Deferred Stock Units

Director Clifton J. Porter II reports the grant of restricted stock units and details of beneficially owned shares in Sabra Health Care REIT.

Summary

• On June 13, 2024, Clifton J. Porter II, a director of Sabra Health Care REIT, Inc. (SBRA), reported transactions related to the company's common stock.
• Porter was granted 9,480 restricted stock units under the Issuer's 2009 Performance Incentive Plan.
• These units vest in equal monthly installments starting July 13, 2024, and ending on the earlier of June 13, 2025, or the day before the next annual stockholders' meeting.
• As of the report, Porter beneficially owns 46,315 shares, which includes 9,480 unvested stock units and 36,311 stock units that have vested but the payment of which has been deferred.
• Each stock unit represents the right to receive one share of Sabra Health Care REIT's Common Stock.
• Porter has also granted power of attorney to Richard K. Matros, Michael Costa, Andor D. Terner, Shelly Heyduk, Mollie Yeh, and Regina Braman to handle SEC filings on his behalf.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices and aligns management interests with shareholders. There are no indications of negative events or concerns.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted stock units.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded REITs. It reflects standard practices for aligning management interests with shareholder value.

Comparison to Industry Standards

• Stock grants and vesting schedules are common compensation practices in the REIT industry.
• Companies like Welltower (WELL) and Ventas (VTR) also utilize stock-based compensation to incentivize executives.
• The vesting schedule and terms are generally in line with industry norms for executive compensation packages.

Stakeholder Impact

• The stock grant aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
• The vesting schedule may incentivize the director to remain with the company, providing stability.

Next Steps

• The restricted stock units will continue to vest monthly according to the specified schedule.
• Porter will be required to report any further changes in beneficial ownership of Sabra Health Care REIT stock.

Key Dates